Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Capital Expenditures (2016 - 2026)

Rockwell Medical filings provide 16 years of Capital Expenditures readings, the most recent being $86000.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 78.23% to $86000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $542000.0, a 46.39% decrease, with the full-year FY2025 number at $542000.0, down 46.39% from a year prior.
  • Capital Expenditures hit $86000.0 in Q4 2025 for Rockwell Medical, down from $229000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $395000.0 in Q4 2024 to a low of -$80000.0 in Q3 2022.
  • Median Capital Expenditures over the past 5 years was $120500.0 (2021), compared with a mean of $132000.0.
  • Biggest five-year swings in Capital Expenditures: plummeted 162.99% in 2022 and later surged 1093.75% in 2024.
  • Rockwell Medical's Capital Expenditures stood at $114000.0 in 2021, then skyrocketed by 146.49% to $281000.0 in 2022, then plummeted by 84.7% to $43000.0 in 2023, then surged by 818.6% to $395000.0 in 2024, then plummeted by 78.23% to $86000.0 in 2025.
  • The last three reported values for Capital Expenditures were $86000.0 (Q4 2025), $229000.0 (Q3 2025), and $164000.0 (Q2 2025) per Business Quant data.